QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.7 USD | +0.19% |
|
+3.12% | +3.52% |
| May. 16 | Everlasting momentum |  |
| May. 16 | Argus Research Adjusts Quest Diagnostics Price Target to $215 From $163 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142.4
USD
Average target price
146.8
USD
Spread / Average Target
+3.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.52% | 15.82B | |
| +18.56% | 84.52B | |
| -27.05% | 72.21B | |
| +4.65% | 27.74B | |
| -7.32% | 17.97B | |
| -0.50% | 17.46B | |
| +6.88% | 13.55B | |
| +5.90% | 13.31B | |
| +69.56% | 12.5B | |
| -1.09% | 12.42B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Baird Adjusts Quest Diagnostics' Price Target to $144 From $138